Advertisement

Pharmacy World & Science

, Volume 30, Issue 4, pp 322–328 | Cite as

Assessing the responsiveness of the Asthma Quality of Life Questionnaire with pharmaceutical care

  • Nadir M. KheirEmail author
  • Lynne Emmerton
  • John P. Shaw
Research Article

Abstract

Objective To assess the responsiveness of the Asthma Quality of Life Questionnaire (AQLQ) in the context of pharmaceutical care delivery New Zealand community pharmacy setting. Setting Community pharmacy practices in three locations in the Otago and Southland region of New Zealand. Method About 62 patients with asthma (17–80 years of age) were recruited in five community pharmacies in the Otago and the Southland region of New Zealand. Patients were randomly assigned to two groups (Group 1 and Group 2). The AQLQ and a study-specific outcomes questionnaire were administered to both groups at baseline (T1), then again (with an additional global Self-Assessment of change question) 3 months later (at T2) after providing the service to Group 1. Responsiveness of the AQLQ was assessed by measuring the ability of the AQLQ to detect within-subject change in patients who subjectively indicated change, and to distinguish between two groups of patients: those who indicated change and those who indicated no change. Additionally, the correlation between the change of the AQLQ scores at T2 and the patients’ self-assessment of change at T2 was estimated and used as means for assessing the AQLQ responsiveness. Main outcome measure Asthma-specific quality of life as measured by the AQLQ and change in quality of life as perceived by participants. Results The results supported the responsiveness of three out of the four domains of the Asthma Quality of Life Questionnaire. The fourth domain, Environmental stimuli, showed weaker responsiveness, and the reasons of this were discussed. Conclusion This study provided data supporting the responsiveness of the AQLQ when used in the context of pharmaceutical care. However, while the AQLQ’s Activity Limitation, Symptoms and Emotional domains reflected adequate sensitivity to change in QoL over time, its Environmental domain was less sensitive. Researchers conducting longitudinal studies utilising the AQLQ in pharmaceutical care interventions should bear this in mind, and should consider the possible reasons for this apparent lack of responsiveness, and its implications.

Keywords

Asthma AQLQ New Zealand Pharmaceutical care Quality of life Responsiveness 

Notes

Funding

This work has been funded by the New Zealand Health Funding Authority and Glaxo-Wellcome-NZ Ltd.

Conflics of interest

None

References

  1. 1.
    Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures—statistics and strategies for evaluation. Control Clin Trials 1991;1(4 Suppl):142S–58S.CrossRefGoogle Scholar
  2. 2.
    Ware JE, Gandek BL, Keller SD. Evaluating instruments used cross-nationally: methods from the IQOLA project. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1996. ISBN-13: 978-0781703321.Google Scholar
  3. 3.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47(3):533–43.PubMedGoogle Scholar
  4. 4.
    Kheir N, van Mil JWF, Shaw J, Sheridan J. Health related quality of life measurement in pharmaceutical care: targeting an outcome that matters. Pharm World Sci 2004;26(3):125–28.PubMedCrossRefGoogle Scholar
  5. 5.
    Kirshner B, Guyatt GH. A methodological framework for assessing health indices. J Chronic Dis 1985;38(1):27–36.PubMedCrossRefGoogle Scholar
  6. 6.
    Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993;147(4):832–8.PubMedGoogle Scholar
  7. 7.
    Ware JE, Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF. The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res 1998;7:235–44.PubMedCrossRefGoogle Scholar
  8. 8.
    Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999;115(5):1265–70.PubMedCrossRefGoogle Scholar
  9. 9.
    Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993;148(3):675–81.PubMedGoogle Scholar
  10. 10.
    Strand LM, Cipolle RJ, Morley PC, et al. Levels of pharmaceutical care: a needs-based approach. Am J Hosp Pharm 1991;48:547–50.PubMedGoogle Scholar
  11. 11.
    Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 1987;40:171–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Rutten-van Molken MP, Custers F, van Doorslaer EK, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995;8(6):888–98.PubMedGoogle Scholar
  13. 13.
    Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993;148(3):675–81.PubMedGoogle Scholar
  14. 14.
    Ware JE, Konsiniski M, Keller SD. SF-36 physical and mental health summary scales: a user’s manual. Boston (MA): The Health Institute; 1994.Google Scholar
  15. 15.
    Raphael D. Defining quality of life. In: Renwick R, Brown I, Nagler M, editors. Quality of life in health promotion and rehabilitation. New York: Sage Publications Inc.; 1996.Google Scholar
  16. 16.
    Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27(3 Suppl):S178–89.PubMedCrossRefGoogle Scholar
  17. 17.
    Scientific Advisory Committee. Instrument Review Criteria. Medical Outcomes Trust Bulletin, September 1995.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Nadir M. Kheir
    • 1
    Email author
  • Lynne Emmerton
    • 2
  • John P. Shaw
    • 3
  1. 1.Pharmacy ProgramQatar UniversityDohaQatar
  2. 2.School of PharmacyUniversity of QueenslandBrisbaneAustralia
  3. 3.School of PharmacyThe University of AucklandAucklandNew Zealand

Personalised recommendations